Sun, Y., Lu, F., Ye, J., Ji, C. (2025). Blinatumomab efficacy differs between newly diagnosed and relapsed/refractory B-ALL: Impact on MRD clearance and survival. Blood. https://doi.org/10.1182/blood-2025-6307